China’s cloud services spending hits US$11.6 billion in first quarter on AI-related demand


Alibaba Group Holding’s cloud computing unit continued to lead the industry in the March quarter, with a commanding 33 per cent market share and a 15 per cent year-on-year revenue growth, Canalys data showed. Hangzhou-based Alibaba owns the South China Morning Post.
Second-ranked Huawei Technologies’ cloud business expanded its market share to 18 per cent, while posting an 18 per cent revenue increase in the same period.
Tencent Holdings’ cloud unit, meanwhile, held a 10 per cent share, but recorded limited revenue growth in the quarter owing to graphics processing unit (GPU) supply constraints and prioritised use of these AI chips for the firm’s internal operations.
These results reflect the robust domestic demand for cloud infrastructure amid a surge in AI-related activities this year, even as service providers contend with US export restrictions that limit China’s access to advanced chips used in data centres.

“Leading cloud providers are actively exploring pathways for AI adoption, unlocking capabilities and building ecosystems through model open-sourcing, while accelerating task execution and scenario delivery via AI agent platforms,” Canalys senior analyst Yi Zhang said in a report on Thursday.

Alibaba Cloud remains the leading provider of cloud infrastructure services in mainland China. Photo: Shutterstock
Alibaba Cloud remains the leading provider of cloud infrastructure services in mainland China. Photo: Shutterstock
  • Related Posts

    China issues new safety rules for OpenClaw. Here are the dos and don’ts

    A unit of China’s Ministry of Industry and Information Technology (MIIT) has issued guidelines on best practices and prohibitions for adopting and using OpenClaw, the popular artificial intelligence agent that…

    Continue reading
    Eli Lilly boosts China footprint with US$3 billion plan to expand supply chain

    Eli Lilly has pledged an additional US$3 billion investment in China over the next decade to strengthen its local supply chain and manufacturing capabilities, deepening the footprint of foreign pharmaceutical…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *